We are live on ! Find out more
ECYT

Endocyte, Inc. Common Stock
ECYT

Delisted

ECYT was delisted on the 20th of December, 2018.

Back to rankings

111 hedge funds and large institutions have $216M invested in Endocyte, Inc. Common Stock in 2013 Q2 according to their latest regulatory filings, with 111 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

89% more call options, than puts

Call options by funds: $1.55M | Put options by funds: $822K

Holders
111
Holders Change
+111
Holders Change %
–
% of All Funds
3.62%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
111
Increased
–
Reduced
–
Closed
–
Calls
$1.55M
Puts
$822K
Net Calls
+$732K
Net Calls Change
+$732K

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
Barclays
101
Barclays
United Kingdom
$27K +$28.1K +2,083 New
Group One Trading
102
Group One Trading
Illinois
$24K +$24.5K +1,815 New
Teacher Retirement System of Texas
103
Teacher Retirement System of Texas
Texas
$24K +$24.7K +1,834 New
SFPIA
104
Stevens First Principles Investment Advisors
California
$20K +$20.2K +1,500 New
PAM
105
Panagora Asset Management
Massachusetts
$19K +$20K +1,483 New
California Public Employees Retirement System
106
California Public Employees Retirement System
California
$17K +$17.5K +1,300 New
SSG
107
Summit Securities Group
New York
$11K +$10.8K +800 New
BlackRock
108
BlackRock
New York
$11K +$11.1K +825 New
Fifth Third Bancorp
109
Fifth Third Bancorp
Ohio
$7K +$6.74K +500 New
Creative Planning
110
Creative Planning
Kansas
$5K +$5.39K +400 New
RIA
111
Regal Investment Advisors
Michigan
$4K +$4.14K +307 New
1 2 3 4
5

ECYT Hedge Fund Activity: Q2 2013 in Review

111 of the 3,065 institutional investors tracked by Wall St. Rank reported a position in Endocyte, Inc. Common Stock (ECYT) for Q2 2013, worth a combined $216M.

Buyers outnumbered sellers: 111 funds opened new ECYT positions and 0 closed out — a net gain of 111 holders — while 0 added to existing stakes and 0 trimmed.

  • 111 institutional investors held Endocyte, Inc. Common Stock (ECYT) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $216M of Endocyte, Inc. Common Stock stock for Q2 2013.
  • 111 funds opened new Endocyte, Inc. Common Stock positions in Q2 2013 and 0 closed out, a net change of +111 holders.

Based on aggregated 13F filings for Q2 2013.